Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+13.82%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$13B
AUM Growth
+$1.56B
(+14%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
1.88%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179
Top Buys
| 1 |
Costco
COST
|
+$130M |
| 2 |
Target
TGT
|
+$78.8M |
| 3 |
Electronic Arts
EA
|
+$77.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$76.1M |
| 5 |
Lockheed Martin
LMT
|
+$63M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$126M |
| 2 |
Starbucks
SBUX
|
+$121M |
| 3 |
Micron Technology
MU
|
+$86.3M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$58.2M |
| 5 |
Kimberly-Clark
KMB
|
+$56.1M |
Sector Composition
| 1 | Technology | 22.35% |
| 2 | Healthcare | 14.05% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Financials | 12.62% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXLA
826
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $615K | ﹤0.01% |
5,164
-2,321
| -31% | -$276K |
|
827
Hope Bancorp
HOPE
$1.41B
| $611K | ﹤0.01% |
40,538
-11,995
| -23% | -$181K |
|
828
Northwest Bancshares
NWBI
$1.83B
| $611K | ﹤0.01% |
+42,318
| New | +$611K |
|
|
INBX
829
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $611K | ﹤0.01% |
+30,421
| New | +$611K |
|
830
Resources Connection
RGP
$167M
| $599K | ﹤0.01% |
44,213
+15,791
| +56% | +$214K |
|
831
Vaalco Energy
EGY
$416M
| $596K | ﹤0.01% |
266,246
+95,735
| +56% | +$214K |
|
|
DZSI
832
DELISTED
DZS Inc. Common Stock
DZSI
| $594K | ﹤0.01% |
38,191
-21,291
| -36% | -$331K |
|
833
Camden National
CAC
$679M
| $592K | ﹤0.01% |
12,377
+3,045
| +33% | +$146K |
|
834
Freshpet
FRPT
$2.61B
| $592K | ﹤0.01% |
3,729
-20,972
| -85% | -$3.33M |
|
835
Global Net Lease
GNL
$1.81B
| $592K | ﹤0.01% |
+32,759
| New | +$592K |
|
836
FS Bancorp
FSBW
$316M
| $589K | ﹤0.01% |
+17,542
| New | +$589K |
|
837
Photronics
PLAB
$1.3B
| $587K | ﹤0.01% |
+45,616
| New | +$587K |
|
838
Ceco Environmental
CECO
$1.67B
| $585K | ﹤0.01% |
+73,710
| New | +$585K |
|
|
AYX
839
DELISTED
Alteryx, Inc.
AYX
| $583K | ﹤0.01% |
+7,028
| New | +$583K |
|
840
IDT Corp
IDT
$1.62B
| $582K | ﹤0.01% |
25,666
| – | – |
|
841
Adeia
ADEA
$1.65B
| $575K | ﹤0.01% |
+99,754
| New | +$575K |
|
|
CNCE
842
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $574K | ﹤0.01% |
114,932
-80,868
| -41% | -$404K |
|
|
CSPR
843
DELISTED
Casper Sleep Inc.
CSPR
| $568K | ﹤0.01% |
78,413
+57,482
| +275% | +$416K |
|
844
Educational Development Corp
EDUC
$9.49M
| $563K | ﹤0.01% |
+33,000
| New | +$563K |
|
845
Wave Life Sciences
WVE
$1.18B
| $563K | ﹤0.01% |
100,374
-357,581
| -78% | -$2.01M |
|
846
Frontline
FRO
$5.02B
| $562K | ﹤0.01% |
+78,657
| New | +$562K |
|
847
1st Source
SRCE
$1.56B
| $558K | ﹤0.01% |
11,729
+6,564
| +127% | +$312K |
|
|
CALA
848
DELISTED
Calithera Biosciences, Inc
CALA
| $558K | ﹤0.01% |
11,524
-93
| -0.8% | -$4.5K |
|
|
LJPC
849
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $557K | ﹤0.01% |
131,423
-61,975
| -32% | -$263K |
|
850
Cyclerion Therapeutics
CYCN
$7.57M
| $553K | ﹤0.01% |
9,910
+4,675
| +89% | +$261K |
|